Acorda Therapeutics, Inc. Soared
Mon, Oct 31, 2022 at 07:28 PM
Acorda Therapeutics, Inc. (ACOR:NASDAQ) shot up at $1.07, representing a gain of 63.4%. On Mon, Oct 31, 2022, ACOR:NASDAQ touched a New 2-Week High of $1.07. The stock appeared on our News Catalysts scanner on Wed, Oct 19, 2022 at 10:41 AM in the 'SPLIT' category. From Mon, Oct 17, 2022, the stock recorded 40.00% Up Days and 54.55% Green Days
About Acorda Therapeutics, Inc. (ACOR:NASDAQ)
Acorda Therapeutics Inc is a biopharmaceutical company. It is engaged in the identification, development & commercialization of novel therapies for the treatment of neurological disorders.
Top 10 Gainers:
- Sonnet BioTherapeutics Holdings, Inc. (SONN:NASDAQ), 66.38%
- Acorda Therapeutics, Inc. (ACOR:NASDAQ), 63.36%
- Bull Horn Holdings Corp. (BHSE:NASDAQ), 44.67%
- Actinium Pharmaceuticals, Inc. (ATNM:NYSEMKT), 39.16%
- Shineco Inc. (SISI:NASDAQ), 37.96%
- Getty Images Holdings Inc. Class A (GETY:NYSE), 34.65%
- Sientra, Inc. (SIEN:NASDAQ), 31.11%
- Renovare Environmental Inc. (RENO:NASDAQ), 28.57%
- Aravive, Inc. (ARAV:NASDAQ), 23.58%
- Mondee Holdings Inc. (MOND:NASDAQ), 22.46%